Teresa Caballero
YOU?
Author Swipe
View article: Long-Term Safety and Effectiveness of Sebetralstat: Interim Analysis of KONFIDENT-S Open-label Extension
Long-Term Safety and Effectiveness of Sebetralstat: Interim Analysis of KONFIDENT-S Open-label Extension Open
Oral sebetralstat enabled compliance with treatment guidelines. No new safety signals were observed, and effectiveness for repeated attacks was consistent with the KONFIDENT trial results.
View article: Analysis of the Effect of Pupil Size and Corneal Aberration on the Optical Performance of Premium Intraocular Lenses
Analysis of the Effect of Pupil Size and Corneal Aberration on the Optical Performance of Premium Intraocular Lenses Open
Background/Objectives: To assess the optical performance of two refractive premium IOLs across pupil sizes and values of corneal spherical aberration (SA). Methods: Two refractive IOLs were evaluated in this study: Tecnis Eyhance and Mini …
View article: Reprogramming breast cancer cells to breast cancer stem cell- <i>like</i> by the POU1F1 transcription factor
Reprogramming breast cancer cells to breast cancer stem cell- <i>like</i> by the POU1F1 transcription factor Open
Breast cancer stem cells (BCSCs) have been proposed as the cause of resistance to conventional treatments and as the origin of breast cancer recurrence and metastasis. However, BCSC origin is not fully understood. Using breast cancer cell …
View article: Correction: The complexities of decision-making associated with on-demand treatment of hereditary angioedema (HAE) attacks
Correction: The complexities of decision-making associated with on-demand treatment of hereditary angioedema (HAE) attacks Open
View article: Hereditary Angioedema with Normal C1 Inhibitor: an Updated International Consensus Paper on Diagnosis, Pathophysiology, and Treatment
Hereditary Angioedema with Normal C1 Inhibitor: an Updated International Consensus Paper on Diagnosis, Pathophysiology, and Treatment Open
View article: Analysis of the optical performance of intraocular lenses using profilometric measurements
Analysis of the optical performance of intraocular lenses using profilometric measurements Open
Purpose The aim of this study was to develop a methodology, based on profilometer measurements to assess the optical behaviour of Intraocular Lenses (IOls). The “Modulation Transfer Function through-object” (MTF through-object) based on ve…
View article: Advent of oral medications for the treatment of hereditary angioedema
Advent of oral medications for the treatment of hereditary angioedema Open
Background Hereditary angioedema (HAE) is a rare genetic disorder characterized by unpredictable, debilitating episodes of submucosal and/or subcutaneous tissue swelling, which may be life‐threatening depending on anatomic location. The tw…
View article: Determinants of Disease Activity in Adults With Hereditary Angioedema due to C1-Esterase Inhibitor Deficiency
Determinants of Disease Activity in Adults With Hereditary Angioedema due to C1-Esterase Inhibitor Deficiency Open
Table 1.Demographic and clinical characteristics of the sample (n = 88) Characteristics Age (mean ± SD), (range) (y) 44.6 ± 14.9, (18-75) Gender, n (%) Female, Male 49 (55.7);39 (44.3)HAE-C1INH, type I, (N, %) HAE-C1INH, type II, (N, %) 87…
View article: The complexities of decision-making associated with on-demand treatment of hereditary angioedema (HAE) attacks
The complexities of decision-making associated with on-demand treatment of hereditary angioedema (HAE) attacks Open
Background Hereditary angioedema (HAE) is characterized by debilitating attacks of tissue swelling in various locations. While guidelines recommend the importance of early on-demand treatment, recent data indicate that many patients delay …
View article: Altered levels of phospholipases C, diacylglycerols, endocannabinoids, and <i>N</i>‐acylethanolamines in patients with hereditary angioedema due to <scp>FXII</scp> mutation
Altered levels of phospholipases C, diacylglycerols, endocannabinoids, and <i>N</i>‐acylethanolamines in patients with hereditary angioedema due to <span>FXII</span> mutation Open
Background Hereditary angioedema (HAE) is a rare genetic disorder characterized by local, self‐limiting edema due to temporary increase in vascular permeability. HAE with normal C1 esterase inhibitor (C1INH) activity includes the form with…
View article: The Chronic Angioedema Registry (CARE): Rationale, Methods and Implementation
The Chronic Angioedema Registry (CARE): Rationale, Methods and Implementation Open
International audience
View article: Hereditary angioedema in Spain: medical care and patient journey
Hereditary angioedema in Spain: medical care and patient journey Open
View article: Understanding The Reasons Not To Treat All HAE Attacks And Patient Satisfaction For On-Demand Treatment (ODT). Results From The HAE Wave II Disease Specific Program™ (DSP™) 2023
Understanding The Reasons Not To Treat All HAE Attacks And Patient Satisfaction For On-Demand Treatment (ODT). Results From The HAE Wave II Disease Specific Program™ (DSP™) 2023 Open
View article: Characteristics of children with hereditary angioedema.
Characteristics of children with hereditary angioedema. Open
View article: Real-life Experience of Subcutaneous Plasma Derived C1-Inhibitor as Long-term Prophylaxis in HAE-C1INH
Real-life Experience of Subcutaneous Plasma Derived C1-Inhibitor as Long-term Prophylaxis in HAE-C1INH Open
View article: Once-Daily Oral Berotralstat for Long-Term Prophylaxis of Hereditary Angioedema: The Open-Label Extension of the APeX-2 Randomized Trial
Once-Daily Oral Berotralstat for Long-Term Prophylaxis of Hereditary Angioedema: The Open-Label Extension of the APeX-2 Randomized Trial Open
Berotralstat was generally well tolerated, provided rapid and sustained reductions in HAE attacks and improved QoL over 96 weeks.
View article: Evolution of Guidelines for the Management of Hereditary Angioedema due to C1 Inhibitor Deficiency
Evolution of Guidelines for the Management of Hereditary Angioedema due to C1 Inhibitor Deficiency Open
Hereditary angioedema (HAE) is a severe and disabling condition characterized by recurrent episodes of subcutaneous or mucosal swelling in the skin and respiratory and gastrointestinal tracts. HAE due to C1-esterase inhibitor deficiency (C…
View article: Expert Review and Consensus on the Treat-to-Target Management of Hereditary Angioedema: From Scientific Evidence to Clinical Practice
Expert Review and Consensus on the Treat-to-Target Management of Hereditary Angioedema: From Scientific Evidence to Clinical Practice Open
Background: Hereditary angioedema with C1 inhibitor deficiency (HAE-C1INH) is a rare disease characterized by swelling episodes. It affects quality of life (QOL) and can be fatal when the upper airways are involved. Treatment is individual…
View article: Self-reported side effects after vaccination against COVID-19 in Honduras
Self-reported side effects after vaccination against COVID-19 in Honduras Open
Background: In December 2019, in the community of Wuhan, in Hubei, China, a series of atypical pneumonia cases with severe course was identified and the new disease was called COVID-19. By March 2020, the World Health Organization declared…
View article: Comparison of the optical quality vision between real post-LASIK myopic laser surgery and the simulated implantation of a phakic IOL in low myopia
Comparison of the optical quality vision between real post-LASIK myopic laser surgery and the simulated implantation of a phakic IOL in low myopia Open
View article: Classification and Treatment of Angioedema without Wheals: A Spanish Delphi Consensus
Classification and Treatment of Angioedema without Wheals: A Spanish Delphi Consensus Open
View article: Understanding the Real Effect of the High-Order Aberrations after Myopic Femto-Lasik
Understanding the Real Effect of the High-Order Aberrations after Myopic Femto-Lasik Open
In this work we try to understand the real effect of increase in aberrations after Femto-LASIK surgery on the patient’s final visual quality, specifically when the visual acuity measurement is considered. A clinical study with 37 eyes of 2…
View article: Hereditary Angioedema Management: From Dealing to Leading
Hereditary Angioedema Management: From Dealing to Leading Open
A two-part digital symposium series entitled ‘Hereditary Angioedema (HAE) Management: From Dealing to Leading,’ took place during the European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress, held in Prague, Czechia, in …
View article: The Icatibant Outcome Survey: 10 years of experience with icatibant for patients with hereditary angioedema
The Icatibant Outcome Survey: 10 years of experience with icatibant for patients with hereditary angioedema Open
In patients with hereditary angioedema (HAE), bradykinin causes swelling episodes by activating bradykinin B 2 receptors. Icatibant, a selective bradykinin B 2 receptor antagonist, is approved for on‐demand treatment of HAE attacks. The Ic…
View article: Analysis and comparison of monofocal, extended depth of focus and trifocal intraocular lens profiles
Analysis and comparison of monofocal, extended depth of focus and trifocal intraocular lens profiles Open
View article: Psychometric study of the SF-36v2 in hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE)
Psychometric study of the SF-36v2 in hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE) Open
Background The generic 36-item Short-Form Health Survey (SF-36v2) has been used to assess health related quality of life in adult patients with hereditary angioedema due to C1-inhibitor deficiency (C1-INH-HAE) even though it has not yet be…
View article: The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update
The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update Open
View article: A multicriteria decision analysis (MCDA) applied to three long-term prophylactic treatments for hereditary angioedema in Spain
A multicriteria decision analysis (MCDA) applied to three long-term prophylactic treatments for hereditary angioedema in Spain Open
Introduction: Hereditary angioedema (HAE) is a rare genetic disease that impairs quality of life and could be life-threatening. The aim of this study was to apply a multicriteria decision analysis to assess the value of three long-term pro…
View article: The international WAO/EAACI guideline for the management of hereditary angioedema—The 2021 revision and update
The international WAO/EAACI guideline for the management of hereditary angioedema—The 2021 revision and update Open
Hereditary angioedema (HAE) is a rare and disabling disease for which early diagnosis and effective therapy are critical. This revision and update of the global WAO/EAACI guideline on the diagnosis and management of HAE provides up‐to‐date…
View article: Hereditary angioedema due to C1 inhibitor deficiency: real-world experience from the Icatibant Outcome Survey in Spain
Hereditary angioedema due to C1 inhibitor deficiency: real-world experience from the Icatibant Outcome Survey in Spain Open
Background The Icatibant Outcome Survey (IOS) is an international registry monitoring the use of icatibant, a bradykinin B 2 receptor antagonist indicated for the acute treatment of hereditary angioedema (HAE) attacks. Our goal was to asse…